These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10440011)

  • 1. CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression.
    Frye MA; Gary KA; Marangell LB; George MS; Callahan AM; Little JT; Huggins T; Corá-Locatelli G; Osuch EA; Winokur A; Post RM
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):349-53. PubMed ID: 10440011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression.
    Frye MA; Dunn RT; Gary KA; Kimbrell TA; Callahan AM; Luckenbaugh DA; Corá-Locatelli G; Vanderham E; Winokur A; Post RM
    Biol Psychiatry; 1999 Apr; 45(8):1049-52. PubMed ID: 10386189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone (TRH): Measurements in human spinal fluid.
    Shambaugh GE; Wilber JF; Montoya E; Ruder H; Blonsky ER
    J Clin Endocrinol Metab; 1975 Jul; 41(1):131-4. PubMed ID: 807591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings.
    Roy A; Wolkowitz OM; Bissette G; Nemeroff CB
    Am J Psychiatry; 1994 Apr; 151(4):600-2. PubMed ID: 7511876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders.
    Sharma RP; Martis B; Rosen C; Jonalagadda J; Nemeroff CB; Bissette G
    J Psychiatr Res; 2001; 35(5):287-91. PubMed ID: 11591431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):335-7. PubMed ID: 8369645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
    Marangell LB; George MS; Bissette G; Pazzaglia P; Huggins T; Post RM
    Arch Gen Psychiatry; 1994 Aug; 51(8):625-8. PubMed ID: 8042911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of immunoreactive CSF TRH in depressed patients.
    Banki CM; Bissette G; Arato M; Nemeroff CB
    Am J Psychiatry; 1988 Dec; 145(12):1526-31. PubMed ID: 3143269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin releasing hormone levels in human cerebrospinal fluid in various neurologic diseases.
    Mitsuma T; Nogimori T; Sahashi K; Adachi K; Kihara M; Murakami K; Nakao N; Gonda M; Fujii K; Okabe Y
    Am J Med Sci; 1986 Mar; 291(3):164-7. PubMed ID: 3082203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of immunoreactive TRH in cerebrospinal fluid and plasma after acute head injury and its clinical significance.
    Wang GL; Zhu C
    Chin Med J (Engl); 1991 Sep; 104(9):764-9. PubMed ID: 1935359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
    Gislason T; Hedner J; Terenius L; Bisette G; Nemeroff CB
    Am Rev Respir Dis; 1992 Sep; 146(3):784-6. PubMed ID: 1381567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives.
    Bartalena L; Placidi GF; Martino E; Falcone M; Pellegrini L; Dell'Osso L; Pacchiarotti A; Pinchera A
    J Clin Endocrinol Metab; 1990 Sep; 71(3):650-5. PubMed ID: 2118539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone and cyclo (His-Pro)-like immunoreactivities in the cerebrospinal fluids of 'normal' infants and adults, and patients with various neuropsychiatric and neurologic disorders.
    Iriuchijima T; Prasad C; Wilber JF; Jayaraman A; Rao JK; Robertson HJ; Rogers DJ
    Life Sci; 1987 Nov; 41(22):2419-28. PubMed ID: 2891013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of thyrotropin-releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin.
    Oliver C; Ben-Jonathan N; Mical RS; Porter JC
    Endocrinology; 1975 Nov; 97(5):1138-43. PubMed ID: 810342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
    Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
    Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-thyroid axis and melatonin in humans: possible interactions in the control of body temperature.
    Mazzoccoli G; Giuliani A; Carughi S; De Cata A; Puzzolante F; La Viola M; Urbano N; Perfetto F; Tarquini R
    Neuro Endocrinol Lett; 2004 Oct; 25(5):368-72. PubMed ID: 15580172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.